Twist Bioscience (TWST) Revenue (2017 - 2026)

Twist Bioscience (TWST) has reported Revenue for 10 consecutive years, with $110.7 million the latest figure, recorded in Q1 2026.

• In Q1 2026, Revenue rose 19.31% year-over-year to $110.7 million; the TTM figure through Mar 2026 stood at $409.5 million (up 17.77% YoY), while the FY2025 annual figure was $376.6 million, up 20.32% from the prior year.
• Revenue grew to $110.7 million in Q1 2026 per TWST's latest filing, from $103.7 million in the prior quarter.
• Across five years, Revenue topped out at $110.7 million in Q1 2026 and bottomed at $48.1 million in Q1 2022.
• Historically, Revenue has averaged $77.1 million across 5 years, with a median of $75.3 million in 2024.
• Annual changes were most pronounced in 2022 — Revenue soared 60.24% — and 2023, when it advanced 13.59%.
• Twist Bioscience's Revenue stood at $54.2 million in 2022, then soared by 31.81% to $71.5 million in 2023, then grew by 24.08% to $88.7 million in 2024, then rose by 16.89% to $103.7 million in 2025, then advanced by 6.77% to $110.7 million in 2026.
• Business Quant data shows TWST's Revenue at $110.7 million in Q1 2026, $103.7 million in Q4 2025, and $99.0 million in Q3 2025.